Healthcare provider profile · identity verified

Alistair C Co, MD

Family Practice · CRYSTAL RIVER, FL · NPI 1194971028

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	250	138
Levothyroxine Sodium	Levothyroxine Sodium	145	60
Amlodipine Besylate	Amlodipine Besylate	140	71
Lisinopril	Lisinopril	128	67
Rosuvastatin Calcium	Rosuvastatin Calcium	128	50
Losartan Potassium	Losartan Potassium	107	52
Metformin Hcl	Metformin Hcl	93	44
Metoprolol Tartrate	Metoprolol Tartrate	91	57
Omeprazole	Omeprazole	91	44
Metoprolol Succinate	Metoprolol Succinate	87	49
Sertraline Hcl	Sertraline Hcl	69	30
Tamsulosin Hcl	Tamsulosin Hcl	69	33
Clopidogrel	Clopidogrel Bisulfate	68	44
Cefuroxime	Cefuroxime Axetil	67	66
Famotidine	Famotidine	67	36
Gabapentin	Gabapentin	65	35
Furosemide	Furosemide	64	44
Trazodone Hcl	Trazodone Hcl	63	26
Eliquis	Apixaban	57	39
Carvedilol	Carvedilol	47	25
Meloxicam	Meloxicam	46	21
Prednisone	Prednisone	42	35
Donepezil Hcl	Donepezil Hcl	41	21
Hydrochlorothiazide	Hydrochlorothiazide	38	20
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	16
Albuterol Sulfate Hfa	Albuterol Sulfate	36	18
Simvastatin	Simvastatin	36	12
Montelukast Sodium	Montelukast Sodium	35	suppressed
Alendronate Sodium	Alendronate Sodium	31	12
Midodrine Hcl	Midodrine Hcl	31	27
Tramadol Hcl	Tramadol Hcl	31	19
Baclofen	Baclofen	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	28
Azithromycin	Azithromycin	28	28
Levofloxacin	Levofloxacin	28	23
Pantoprazole Sodium	Pantoprazole Sodium	28	16
Spironolactone	Spironolactone	27	18
Fluoxetine Hcl	Fluoxetine Hcl	26	11
Alprazolam	Alprazolam	25	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	14
Jardiance	Empagliflozin	25	18
Xarelto	Rivaroxaban	25	15
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Finasteride	Finasteride	24	suppressed
Allopurinol	Allopurinol	23	suppressed
Ezetimibe	Ezetimibe	23	11
Methylprednisolone	Methylprednisolone	23	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Lorazepam	Lorazepam	21	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	12
Aripiprazole	Aripiprazole	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	18
Divalproex Sodium	Divalproex Sodium	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	11
Glipizide	Glipizide	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Temazepam	Temazepam	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Potassium Chloride	Potassium Chloride	17	suppressed
Cephalexin	Cephalexin	16	16
Glimepiride	Glimepiride	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	11
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Topiramate	Topiramate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	14
Glipizide Er	Glipizide	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Ranolazine Er	Ranolazine	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Dutasteride	Dutasteride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error